ANXA2 and precursor B-cell acute lymphoblastic leukemia: Secondly, addition of A2ti or ANXA2 Ab to matrigel containing WT MSC, IGF1 and PLG prevented an increase of primary BCR-ABL1+ B-ALL cells via IGF1 release from the matrix (Fig. 6C).